Pressmeddelanden från Spermosens

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Spermosens AB (publ)YEAR-END REPORT JANUARY – DECEMBER 2025 - CORRECTED 11 feb 09:05

Spermosens AB (publ)YEAR-END REPORT JANUARY – DECEMBER 2025 26 jan 13:40

Spermosens and RSI sign Memorandum of Understanding to advance male fertility diagnostics in the US 16 jan 10:22

Spermosens and Sapyen sign Memorandum of Understanding to advance male fertility diagnostics 09 dec 2025 08:45

Spermosens shares progress and plans for partner-driven commercialization 08 dec 2025 13:41

Spermosens announces outcome of exercise of warrants series TO 4 24 nov 2025 17:12

Spermosens announces last day of trading for warrants of series TO 4 18 nov 2025 10:21

Spermosens receives patent approval in China 12 nov 2025 09:04

Spermosens AB (publ) INTERIM REPORT JANUARY - SEPTEMBER 2025 04 nov 2025 17:21

Spermosens receives patent approval in Israel 03 nov 2025 12:31

Spermosens receives patent approval in Mexico 22 okt 2025 11:17

Spermosens receives patent approval in Canada 20 aug 2025 09:38

Spermosens AB (publ) INTERIM REPORT JANUARY - JUNE 2025 07 aug 2025 08:30

Spermosens provides status update following successful clinical study 17 jun 2025 14:16

Spermosens announces outcome of exercise of warrants series TO 5 16 jun 2025 11:15

Spermosens AB Announces Results from Annual General Meeting on 16 June 2025 13 jun 2025 13:04

Chairman and CEO of Spermosens exercise TO5 warrants 11 jun 2025 12:48

Spermosens concludes clinical study with statistically significant results supporting the diagnostic value of JUNO-Checked 05 jun 2025 21:09

The capital raise and issue announced in March 2025 is approved by Inspectorate of Strategic Products 05 jun 2025 12:27

Last day of trading in warrants series TO 5 in Spermosens is 12 June 2025 02 jun 2025 08:45

The subscription price for warrants of series TO 5 has been determined – the exercise period begins today 26 maj 2025 12:06

Spermosens publishes annual report for the financial year 2024 26 maj 2025 12:04

Spermosens publicerar årsredovisning för räkenskapsåret 2024 15 maj 2025 08:51

NOTICE OF ANNUAL GENERAL MEETING 2025 IN SPERMOSENS AB (publ)15 maj 2025 08:50

KALLELSE TILL ÅRSSTÄMMA 2025 I SPERMOSENS AB (publ)07 maj 2025 09:10

Spermosens AB (publ)INTERIM REPORT JANUARY - MARCH 2025 30 apr 2025 12:48

Spermosens provides update on clinical progress, partner discussions and financing 02 apr 2025 09:56

Spermosens reports positive second interim results from clinical study 31 mar 2025 08:45

Spermosens appoints Dr. Jaime Castillo-León as chief technology officer to drive innovation and technology development 27 mar 2025 09:56

Spermosens AB announces strategic collaboration with Scalania AG to accelerate development and market readiness 21 mar 2025 12:28

Spermosens publishes peer-reviewed article on JUNO-Checked technology 14 mar 2025 12:44

Spermosens presents plan to achieve positive cash flow following recent strategic investment 05 mar 2025 14:30

Spermosens announces outcome of TO3 warrants 04 mar 2025 13:33

Spermosens secures SEK 10.8 million strategic investment through directed issue, fulfilling capital need until cash positive 24 feb 2025 15:49

Spermosens announces last day of trading for warrants of series TO3 19 feb 2025 15:54

Spermosens AB announces shareholding changes following latest directed issue 17 feb 2025 16:00

Announcement from the Extraordinary General Meeting of Spermosens AB (publ) on 17 February 2025 13 feb 2025 20:54

Spermosens AB (publ) YEAR-END REPORT JANUARY - DECEMBER 2024 13 feb 2025 13:26

Spermosens adjusts publication date for Year-end report 2024 15 jan 2025 14:45

Kallelse till extra bolagsstämma i Spermosens AB 14 jan 2025 12:09

Spermosens announces relocation to a smaller office at Medicon Village 30 dec 2024 11:54

Spermosens year-end status update: Strong progress and promising outlook for 2025 23 dec 2024 15:00

Spermosens announces the last day of trading in BTU and the first day of trading in warrants series TO 5 and TO 6 23 dec 2024 08:53

Spermosens carries out directed issues of approx. MSEK 5.59, takes up credit facility of MSEK 1.00, and receives proposal of directed issues of approx. MSEK 0.39 19 dec 2024 12:21

Spermosens announces positive results from ongoing clinical study 27 nov 2024 21:00

Spermosens publishes outcome in rights issue 22 nov 2024 08:00

The subscription period in Spermosens’ rights issue of units ends on Monday, 25 November 2024 20 nov 2024 10:39

Spermosens' commercial strategy targets billion-dollar sperm bank market through global partnerships 18 nov 2024 14:26

Spermosens provides update on clinical study progress 11 nov 2024 08:00

The subscription period in Spermosens’ rights issue of units begins today 06 nov 2024 20:00

Spermosens publishes information memorandum due to upcoming rights issue of units 05 nov 2024 12:17

Spermosens announces advancements in second-generation JUNO-Checked system 04 nov 2024 20:00

Kommuniké från extra bolagsstämma i Spermosens AB (publ)04 nov 2024 20:00

Announcement from the Extraordinary General Meeting of Spermosens AB (publ)30 okt 2024 13:20

Spermosens reduces spending by focusing on clinical study and business development 24 okt 2024 20:00

Spermosens AB (publ)INTERIM REPORT JANUARY - SEPTEMBER 2024 23 okt 2024 13:25

Spermosens reports strong progress in clinical study 16 okt 2024 14:30

Spermosens signs memorandum of understanding for commercial partnership in Japan 15 okt 2024 14:10

Spermosens receives notice of allowance for broad US patent covering JUNO-Checked technology 04 okt 2024 14:00

Spermosens recruits first couple for clinical study on next-generation male fertility diagnostic product 03 okt 2024 21:13

Kallelse till extra bolagsstämma i Spermosens AB (publ) för beslut om emission 03 okt 2024 21:05

Spermosens carries out a rights issue of units of approximately SEK 22.7 million 25 sep 2024 20:00

Spermosens next-generation male fertility diagnostic product ready for clinical study 26 aug 2024 11:39

Spermosens passes an important milestone receiving approval for significant clinical study.20 aug 2024 20:00

Spermosens AB (publ) INTERIM REPORT JANUARY - JUNE 2024 14 jul 2024 08:00

Spermosens accelerates its US business development activities in collaboration with Scan MedPartners 02 jul 2024 09:07

BioStock: Spermosens - helping couples succeed in babymaking 02 jul 2024 09:07

BioStock: Spermosens - hjälper par med barnlöshet 25 jun 2024 15:58

Spermosens AB Announces Revised Strategy 03 jun 2024 18:00

Spermosens genomför effektivisering av marknadskommunikation och ändrar från svenska till engelska 30 maj 2024 20:00

Spermosens AB (publ) offentliggör delårsrapport januari - mars 2024 16 maj 2024 12:00

Spermosens - Omvandling av betalda tecknade units och första dag för handel med teckningsoptioner 10 maj 2024 15:11

Kommuniké från Spermosens årsstämma 23 apr 2024 19:57

Spermosens utser Tore Duvold till ny VD 19 apr 2024 20:55

Spermosens AB (publ) offentliggör utfall i företrädesemission och meddelar flaggning 19 apr 2024 15:30

Spermosens erhåller patentgodkännande i Singapore 18 apr 2024 12:18

KORRIGERING: Spermosens årsredovisning för 2023 har idag publicerats på bolagets webbplats.18 apr 2024 11:30

Spermosens årsredovisning för 2023 har idag publicerats på bolagets webbplats.16 apr 2024 21:30

Sista dagen att teckna units i Spermosens pågående företrädesemission närmar sig 12 apr 2024 08:00

KALLELSE TILL ÅRSSTÄMMA 2024 I SPERMOSENS AB (publ)11 apr 2024 08:15

Biostock: Investor Pitch: Spermosens 08 apr 2024 08:45

BioStock: Spermosens bidrag till att lösa ofrivillig barnlöshet 03 apr 2024 08:00

Idag inleds teckningsperioden i Spermosens företrädesemission av units 28 mar 2024 09:29

Spermosens AB (publ) offentliggör EU-tillväxtprospekt med anledning av företrädesemission av units 25 mar 2024 14:35

Kommuniké från extra bolagsstämma i Spermosens AB (publ)21 mar 2024 20:00

Spermosens AB anställer Dr. Maria Liljander som CSO 14 mar 2024 20:00

Spermosens siktar mot en miljardmarknad 05 mar 2024 20:00

Spermosens AB (publ) säkerställer 84 procent teckningsgrad i förestående företrädesemission 22 feb 2024 21:05

Spermosens publicerar - White Paper 21 feb 2024 08:40

Korrigering: Kallelse till extra bolagsstämma i Spermosens AB (publ) för beslut om nyemission 20 feb 2024 21:00

Kallelse till extra bolagsstämma i Spermosens AB (publ) för beslut om nyemission 20 feb 2024 20:59

Styrelsen i Spermosens AB (publ) beslutar om en företrädesemission av units om cirka 28,8 MSEK 16 feb 2024 08:00

Spermosens AB (publ) optionsinlösen avslutad 09 feb 2024 08:00

Spermosens AB (publ) Bokslutskommuniké 2023 26 jan 2024 19:00

Teckningskurs fastställd för TO 2 18 jan 2024 09:30

Spermosens erhåller patentgodkännande i Australien 16 nov 2023 17:51

Spermosens publicerar första resultat från användning av JUNO-Checked 06 nov 2023 18:00

Spermosens erhåller patentgodkännande i Sydkorea 27 okt 2023 14:44

Spermosens JUNO-Checked system redo för försäljning 24 okt 2023 18:00

Spermosens utser valberedning inför årsstämma 2024